Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmedium-chain fatty acid omega-hydroxylase activity

CYP4A11 CYP4A22

3.29e-0521152GO:0140981
GeneOntologyMolecularFunction16-hydroxypalmitate dehydrogenase activity

CYP4A11 CYP4A22

3.29e-0521152GO:0103002
GeneOntologyCellularComponentnuclear pore nuclear basket

RGPD4 NUP35 RGPD3

1.45e-04181213GO:0044615
DomainDUF1220

NBPF11 NBPF9 NBPF14

3.71e-05111163PF06758
DomainNBPF_dom

NBPF11 NBPF9 NBPF14

3.71e-05111163IPR010630
DomainNBPF

NBPF11 NBPF9 NBPF14

3.71e-05111163PS51316
DomainHAT_MYST-type

KAT7 KAT6B

3.78e-0451162IPR002717
DomainMOZ_SAS

KAT7 KAT6B

3.78e-0451162PF01853
DomainMYST_HAT

KAT7 KAT6B

3.78e-0451162PS51726
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

USP53 RAPGEF6 HIVEP2 TEX2 ESYT1 SIPA1L3 ANKRD26 SORBS1 DPP8 CBL FSIP2 FAM171A1 VPS13D PIK3C2A STARD9 KIAA1217 OSBPL8 FAM83G SRRM2

1.61e-108611211936931259
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

RGPD4 SGIP1 BCLAF1 ITSN1 SYNPO SORBS1 GPRIN1 RGPD3 SRRM2 PRRC2B BRWD1

5.88e-102311211116452087
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

RGPD4 SGIP1 BCLAF1 ITSN1 SIPA1L3 TRIOBP SYNPO SORBS1 BCOR TTC3 DCX FAM171A1 NCOR1 ARHGEF7 KIAA1217 RGPD3 DLG2 PRRC2B

6.86e-099631211828671696
Pubmed

A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.

NBPF8 NBPF11 NBPF19 NBPF9 NBPF14

9.13e-0921121516079250
Pubmed

BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.

BCOR NCOR1 ARID5B SUGP1 PRRC2B

1.89e-0824121533722704
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

USP53 RAPGEF6 ITSN1 MAP3K1 NBPF19 NCOR1 ZNF469 NBPF9 UNK INAVA NBPF14 MGRN1

3.81e-084301211235044719
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

RGPD4 SP100 MYH7B BCLAF1 ITSN1 SIPA1L3 UGGT1 ANKRD26 SYNPO NEB TTC3 NUP35 ABCB1 NCOR1 CEBPZ STARD9 RGPD3 DLG2 RBFA PRRC2B

1.29e-0714421212035575683
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

ITSN1 ANKRD26 SORBS1 BCOR NCOR1 NFATC1 WDCP KIAA1217 RECQL5 ARID5B UNK FAM135A PRRC2B

1.50e-075881211338580884
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

NBPF8 ARHGAP23 BCLAF1 SYNPO NBPF11 NEB STARD9 KIAA1217 NBPF9 RGPD3 SRRM2 NBPF14

2.55e-075131211225798074
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

USP53 TEX2 BCLAF1 AKNA TRIOBP SYNPO BCOR TRANK1 ARHGEF7 UNK KAT6B MGRN1

3.53e-075291211214621295
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

SGIP1 TEX2 ITSN1 SYNPO SORBS1 GPRIN1 PIK3C2A ARHGEF7 DLG2 SRRM2

4.08e-073471211017114649
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

USP53 ESYT1 ITSN1 SIPA1L3 ANKRD26 SORBS1 SPATA2 NCOR1 WDCP KIAA1217 FAM83G UNK PRRC2B BRWD1

1.72e-068531211428718761
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

RAPGEF6 ESYT1 ANKRD26 TRIOBP GPRIN1 CBL FAM171A1 KIAA1217 OSBPL8 FAM135A

2.33e-064211211036976175
Pubmed

The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.

NUSAP1 GPR50 TEX2 ESYT1 SIPA1L3 UGGT1 GPRIN1 NUP35 PIK3C2A SUGP1 OSBPL8 UNK WIPF2 FAM135A PRRC2B

2.35e-0610071211534597346
Pubmed

Evolutionary history and genome organization of DUF1220 protein domains.

NBPF8 NBPF9 NBPF14

4.84e-0610121322973535
Pubmed

A human MAP kinase interactome.

USP53 SP100 HIVEP2 ITSN1 SYNPO SORBS1 NEB CBL ARHGEF7 WIPF2

8.21e-064861211020936779
Pubmed

USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation.

ESYT1 NEB ARHGEF7 KIAA1217

8.42e-0637121432133736
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

HIVEP2 ITSN1 SIPA1L3 TRIOBP SYNPO SORBS1 TTC3 RYR3 ZNF836 GTF3A ARID5B OSBPL8 DLG2 OLIG2 MTUS2 BRWD1

1.03e-0512851211635914814
Pubmed

Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.

CYP4A11 CYP4A22

1.20e-052121215611369
Pubmed

Loss of syk kinase during IgE-mediated stimulation of human basophils.

CBL SYK

1.20e-052121215577829
Pubmed

CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy.

NFATC1 SYK

1.20e-052121231921172
Pubmed

[Effects of Bufalin on SYK and CBL family proteins in induction of HL-60 cell apoptosis].

CBL SYK

1.20e-052121219236749
Pubmed

Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.

CHGA PLG

1.20e-052121211342539
Pubmed

Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.

CYP4A11 CYP4A22

1.20e-052121223641057
Pubmed

Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells.

CBL SYK

1.20e-052121228827787
Pubmed

The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation.

CBL SYK

1.20e-052121211742985
Pubmed

The Blood Pressure-Lowering Effect of 20-HETE Blockade in Cyp4a14(-/-) Mice Is Associated with Natriuresis.

CYP4A11 CYP4A22

1.20e-052121228912346
Pubmed

Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.

CYP4A11 CYP4A22

1.20e-052121224413902
Pubmed

Syk tyrosine 317 negatively regulates osteoclast function via the ubiquitin-protein isopeptide ligase activity of Cbl.

CBL SYK

1.20e-052121219419964
Pubmed

Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: developmental and hormonal regulation in liver and kidney.

CYP4A11 CYP4A22

1.20e-05212128031839
Pubmed

Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.

CBL SYK

1.20e-052121210570266
Pubmed

Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.

CBL SYK

1.20e-05212129857068
Pubmed

Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein.

CYP4A11 CYP4A22

1.20e-052121210860550
Pubmed

Cool-1-mediated inhibition of c-Cbl modulates multiple critical properties of glioblastomas, including the ability to generate tumors in vivo.

CBL ARHGEF7

1.20e-052121224458840
Pubmed

Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.

CYP4A11 CYP4A22

1.20e-052121211320253
Pubmed

The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase.

CBL SYK

1.20e-052121210617633
Pubmed

Characterization of the CYP4A11 gene, a second CYP4A gene in humans.

CYP4A11 CYP4A22

1.20e-052121212464262
Pubmed

Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta.

CYP4A11 CYP4A22

1.20e-052121215066132
Pubmed

20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.

CYP4A11 CYP4A22

1.20e-052121223825080
Pubmed

Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel.

CYP4A11 CYP4A22

1.20e-052121216691295
Pubmed

The P450 gene superfamily: recommended nomenclature.

CYP4A11 CYP4A22

1.20e-05212123829886
Pubmed

Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice.

CYP4A11 CYP4A22

1.20e-052121229277328
Pubmed

Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population.

CYP4A11 CYP4A22

1.20e-052121221820496
Pubmed

Renal function and vasomotor activity in mice lacking the Cyp4a14 gene.

CYP4A11 CYP4A22

1.20e-052121220943934
Pubmed

The rat clofibrate-inducible CYP4A subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes.

CYP4A11 CYP4A22

1.20e-05212122766933
Pubmed

With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.

BIRC6 ABCB1

1.20e-052121228358418
Pubmed

Role of Syk in Fc gamma receptor-coupled tyrosine phosphorylation of Cbl in a manner susceptible to inhibition by protein kinase C.

CBL SYK

1.20e-052121210540342
Pubmed

CBL/CAP Is Essential for Mitochondria Respiration Complex I Assembly and Bioenergetics Efficiency in Muscle Cells.

SORBS1 CBL

1.20e-052121236834818
Pubmed

Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation.

CYP4A11 CYP4A22

1.20e-052121217112342
Pubmed

High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE.

CYP4A11 CYP4A22

1.20e-052121230088983
Pubmed

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

CYP4A11 CYP4A22

1.20e-052121219208908
Pubmed

A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.

RGPD4 BCOR NCOR1 KIAA1217 RGPD3 ARID5B

1.28e-05146121623892456
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

TEX2 BCLAF1 ESYT1 ITSN1 UGGT1 ANKRD26 TRIOBP GPRIN1 TTC3 FAM171A1 PIK3C2A CEBPZ CLPTM1 MRPL48 OSBPL8 SRRM2 FAM135A

1.60e-0514871211733957083
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

RAPGEF6 GCFC2 BCLAF1 ITSN1 BCOR GPRIN1 NCOR1 MYO3A PACS2 UNK KAT6B SRRM2

1.73e-057741211215302935
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

ZNF862 PCDH11Y AKNA NBPF19 NCOR1 STARD9 SRRM2

1.83e-05233121737704626
Pubmed

Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.

TEX2 SIPA1L3 SORBS1 NCOR1 VPS13D WDCP KIAA1217 CLPTM1 SYK KAT6B

1.91e-055361211015840001
Pubmed

Exchangeable gene trap using the Cre/mutated lox system.

TEX2 SIPA1L3 SORBS1 NCOR1 VPS13D WDCP KIAA1217 CLPTM1 SYK KAT6B

1.97e-055381211010512203
Pubmed

Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?

NBPF8 CHGA NBPF11 NBPF9 RGPD3 NBPF14

3.02e-05170121623314748
Pubmed

Expression of murine cyclin B1 mRNAs and genetic mapping of related genomic sequences.

CYP4A11 CYP4A22 PLG

3.23e-051812131387105
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

ZNF518A TRANK1 PPIP5K1 KAT6B SRRM2

3.28e-0510412159205841
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

ZNF862 SIPA1L3 PACS2 PRRC2B MGRN1

3.43e-0510512159628581
Pubmed

Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice.

CYP4A11 CYP4A22

3.59e-05312122354437
Pubmed

Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.

ITSN1 CBL

3.59e-053121216914641
Pubmed

Cbl-PI3K interaction regulates Cathepsin K secretion in osteoclasts.

CBL PIK3C2A

3.59e-053121231299383
Pubmed

Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils.

CBL SYK

3.59e-053121212435267
Pubmed

Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.

MAP3K1 NCOR1

3.59e-053121211971970
Pubmed

Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.

ITSN1 CBL

3.59e-053121222158968
Pubmed

Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not OLIG2.

BCOR OLIG2

3.59e-053121232790583
Pubmed

Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.

CYP4A11 CYP4A22

3.59e-053121228270609
Pubmed

Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases.

CBL SYK

3.59e-05312129535867
Pubmed

The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase.

CBL SYK

3.59e-05312129103201
Pubmed

H19/Mir-130b-3p/Cyp4a14 potentiate the effect of praziquantel on liver in the treatment of Schistosoma japonicum infection.

CYP4A11 CYP4A22

3.59e-053121237659685
Pubmed

A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans.

CYP4A11 CYP4A22

3.59e-05312129271096
Pubmed

The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation.

ESYT1 ROS1

3.59e-053121222659450
Pubmed

Profiling Glioblastoma Cases with an Expression of DCX, OLIG2 and NES.

DCX OLIG2

3.59e-053121234948016
Pubmed

Mouse cathepsin D gene: molecular organization, characterization of the promoter, and chromosomal localization.

CYP4A11 CYP4A22

3.59e-05312128011168
Pubmed

Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia.

UGGT1 ABCB1

3.59e-053121228025333
Pubmed

A novel calmodulin-β-PIX interaction and its implication in receptor tyrosine kinase regulation.

CBL ARHGEF7

3.59e-053121222588125
Pubmed

The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

CYP4A11 CYP4A22

3.59e-05312121991046
Pubmed

Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice.

CYP4A11 CYP4A22

3.59e-053121219713718
Pubmed

Peroxisome proliferator activated receptor alpha regulates a male-specific cytochrome P450 in mouse liver.

CYP4A11 CYP4A22

3.59e-053121215313227
Pubmed

The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.

CBL SYK

3.59e-053121220670954
Pubmed

Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.

SYNPO CBL FAM83G SRRM2 WIPF2

3.93e-05108121519531213
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

RGPD4 SGIP1 TEX2 BCLAF1 TRIOBP SYNPO SORBS1 GPRIN1 BIRC6 ARHGEF7 KIAA1217 RGPD3 OSBPL8 DLG2

4.40e-0511391211436417873
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

SIPA1L3 BCOR SPATA2 NCOR1 PIK3C2A DCLRE1A

4.69e-05184121632908313
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

GCFC2 TEX2 ITSN1 UGGT1 BIRC6 CEBPZ CLPTM1 SUGP1 OSBPL8 UNK DCLRE1A

5.29e-057331211134672954
Pubmed

Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.

TEX2 BCLAF1 ESYT1 GPRIN1 OSBPL8 FAM135A

5.77e-05191121631177093
Pubmed

Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes.

ITSN1 CBL BIRC6 PIK3C2A

5.85e-0560121434761192
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ARHGAP23 SIPA1L3 ANKRD26 BIRC6 ZNF836 VPS13D OSBPL8 FAM135A TMEM63A

5.97e-05493121915368895
Pubmed

CAP defines a second signalling pathway required for insulin-stimulated glucose transport.

SORBS1 CBL

7.17e-054121211001060
Pubmed

Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK.

BCOR NCOR1

7.17e-054121215878880
Pubmed

Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal.

CYP4A11 CYP4A22

7.17e-05412128334987
Pubmed

The Syk-binding ubiquitin ligase c-Cbl mediates signaling-dependent B cell receptor ubiquitination and B cell receptor-mediated antigen processing and presentation.

CBL SYK

7.17e-054121222451666
Pubmed

DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk.

CBL SYK

7.17e-054121227614019
Pubmed

CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.

CBL SYK

7.17e-054121225965880
Pubmed

Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases.

CBL SYK

7.17e-05412128798454
Pubmed

The Cbl proteins are binding partners for the Cool/Pix family of p21-activated kinase-binding proteins.

CBL ARHGEF7

7.17e-054121212935897
Pubmed

Platelet alpha IIb-beta 3 integrin engagement induces the tyrosine phosphorylation of Cbl and its association with phosphoinositide 3-kinase and Syk.

CBL SYK

7.17e-054121211042121
Pubmed

Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling.

SORBS1 CBL

7.17e-054121215031295
Pubmed

Differences in metabolite burden of di(2-ethylhexyl)phthalate in pregnant and postpartum dams and their offspring in relation to drug-metabolizing enzymes in mice.

CYP4A11 CYP4A22

7.17e-054121222159897
InteractionYWHAZ interactions

RAPGEF6 HIVEP2 TEX2 ESYT1 SIPA1L3 ANKRD26 SYNPO SORBS1 DPP8 NEB BCOR SPATA2 CBL MAP3K1 FSIP2 FAM171A1 NCOR1 MYO3A VPS13D PIK3C2A ARHGEF7 STARD9 OSBPL8 FAM83G PACS2 UNK

3.46e-08131911826int:YWHAZ
InteractionSYNE3 interactions

TEX2 ESYT1 SIPA1L3 UGGT1 ANKRD26 SORBS1 SPATA2 NCOR1 PIK3C2A WDCP KIAA1217 OSBPL8 UNK PRRC2B

3.35e-0744411814int:SYNE3
InteractionYWHAG interactions

USP53 RAPGEF6 HIVEP2 ARHGAP23 BCLAF1 ESYT1 SIPA1L3 ANKRD26 SYNPO SORBS1 CBL MAP3K1 FAM171A1 VPS13D PIK3C2A ARHGEF7 STARD9 OSBPL8 FAM83G PACS2 UNK PPIP5K1 SRRM2

8.02e-07124811823int:YWHAG
InteractionYWHAH interactions

USP53 RAPGEF6 HIVEP2 TEX2 ESYT1 SIPA1L3 ANKRD26 SORBS1 DPP8 CBL FAM171A1 VPS13D PIK3C2A ARHGEF7 STARD9 KIAA1217 OSBPL8 FAM83G PACS2 DCLRE1A SRRM2

1.54e-06110211821int:YWHAH
InteractionSFN interactions

USP53 RAPGEF6 TEX2 SIPA1L3 ANKRD26 SORBS1 DPP8 NEB CBL FAM171A1 KAT7 PIK3C2A FAM83G PACS2 SRRM2

1.28e-0569211815int:SFN
InteractionFGFR4 interactions

ITSN1 ANKRD26 TRIOBP SORBS1 SPATA2 GPRIN1 CBL FAM171A1 CLEC4A ROS1 WIPF2 FAM135A

1.59e-0545811812int:FGFR4
InteractionYWHAB interactions

RAPGEF6 ARHGAP23 ESYT1 SIPA1L3 ANKRD26 SORBS1 DPP8 NEB CBL FAM171A1 VPS13D PIK3C2A ARHGEF7 STARD9 FAM83G PACS2 UNK SRRM2

2.45e-05101411818int:YWHAB
InteractionYWHAE interactions

RAPGEF6 HIVEP2 ESYT1 SIPA1L3 ANKRD26 SORBS1 DPP8 SPATA2 TTC3 CBL DCX MAP3K1 FAM171A1 PIK3C2A ARHGEF7 OSBPL8 FAM83G PACS2 UNK SRRM2

3.92e-05125611820int:YWHAE
InteractionCBLB interactions

ITSN1 SORBS1 CBL NFATC1 ARHGEF7 SYK

5.93e-051151186int:CBLB
Cytoband1q21.1

NBPF8 NBPF11 NBPF9 NBPF14

2.28e-056212141q21.1
GeneFamilyNeuroblastoma breakpoint family

NBPF8 NBPF11 NBPF19 NBPF9 NBPF14

5.69e-0823835662
GeneFamilyPDZ domain containing

RAPGEF6 ARHGAP23 SIPA1L3 SYNPO2L DLG2

6.74e-041528351220
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

HIVEP2 ZNF862 ZNF518A ZNF10 ZNF836 ZNF469 ZNF26 GTF3A ZNF556 ZNF408

1.63e-03718831028
GeneFamilyTetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome

RGPD4 TTC3 TRANK1 RGPD3

1.94e-03115834769
GeneFamilyZinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases

KAT7 KAT6B

2.40e-031683266
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

ARHGAP23 ITSN1 TRIOBP ARHGEF7 OSBPL8

2.59e-03206835682
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

KAT7 KAT6B

2.71e-0317832486
CoexpressionCUI_TCF21_TARGETS_2_DN

HIVEP2 SGIP1 FAM13C TEX2 ITSN1 SYNPO SORBS1 PARP14 CBL ZNF518A ABCB1 VSTM4 NCOR1 CLEC4A P3H2 ARID5B OSBPL8 TMEM150C FAM135A SDC2

1.47e-0985411820M1533
CoexpressionCUI_TCF21_TARGETS_2_DN

HIVEP2 SGIP1 FAM13C TEX2 ITSN1 SYNPO SORBS1 PARP14 CBL ZNF518A ABCB1 VSTM4 NCOR1 CLEC4A P3H2 ARID5B OSBPL8 TMEM150C FAM135A SDC2

2.86e-0988811820MM1018
CoexpressionGSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN

MYH7B ANKRD26 PARP14 GPRIN1 CYP4A22 ZNF469 NFATC1 SYK

3.44e-061991188M7341
CoexpressionGSE7852_LN_VS_THYMUS_TREG_UP

BCLAF1 AKNA SYNPO BCOR ABCB1 UNK WIPF2 TMEM63A

3.57e-062001188M5737
CoexpressionVERHAAK_GLIOBLASTOMA_PRONEURAL

PCDH11Y BCOR TTC3 DCX KAT7 INAVA OLIG2

1.60e-051771187M2115
CoexpressionLAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM

ITSN1 SIPA1L3 BCOR ZC3H6 NCOR1 DLG2 PLG KAT6B SRRM2 TMEM63A

1.97e-0541711810M39224
CoexpressionGSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN

ESYT1 CHRM5 KAT7 GTF3A NEIL3 DCLRE1A TMEM63A

3.18e-051971187M7683
CoexpressionGSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP

RAPGEF6 AKNA PARP14 CBL ZNF518A NCOR1 TMEM150C

3.39e-051991187M6443
CoexpressionGSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN

ZNF862 ITSN1 SIPA1L3 PARP14 TTC3 DLG2 PRRC2B

3.39e-051991187M7472
CoexpressionGSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN

ZNF862 SYNPO2L TTC3 FAM83G PPIP5K1 FAM135A TMEM63A

3.50e-052001187M6018
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

USP53 SP100 BCLAF1 TTC3 NCOR1 ARID5B OSBPL8 BRWD1

7.47e-081991218c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass

TEX2 MYH7B NEB TRANK1 OSBPL8 PRRC2B

7.90e-06173121642c911ed16fabdabef063830e8407192d8bde950
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RYR3 NBPF19 TMEM150C GOLIM4 ROS1 NBPF14

8.16e-061741216ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ABCB1 KIAA1217 ROS1

8.16e-061741216e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NUSAP1 LHX3 GDF9 NUP35 TMEM150C NEIL3

1.02e-051811216b203b616584cdbd0bbb0e382b2916d0bd49d3526
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NUSAP1 LHX3 GDF9 NUP35 TMEM150C NEIL3

1.02e-051811216c748c16fd20d1949d33ff6290dc9d9016c4dc86c
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

BIRC6 MAP3K1 VPS13D TRANK1 PIK3C2A GOLIM4

1.19e-05186121603db813598b67b1e08f759758a1c2023396921fa
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC3 RYR3 ABCB1 TRANK1 ARID5B SRRM2

1.47e-0519312161aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCelldroplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESYT1 CHGA NEB NCOR1 SRRM2 PRRC2B

1.51e-0519412163a3ecedcdc7691cf21775818b598208fcb980c29
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESYT1 CHGA NEB NCOR1 SRRM2 PRRC2B

1.51e-0519412160b023de48ed8a550d169bbe954881eb04bf4f981
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

BIRC6 FAM171A1 PIK3C2A KIAA1217 FAM135A BRWD1

1.80e-052001216dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9

SIPA1L3 INAVA SRRM2 ANKFN1 WIPF2

7.39e-051591215655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYH7B SIPA1L3 BCOR ZNF518A ZNF556

9.06e-051661215c8fd241088de27c6e741a5dfee3cd770183b6bcb
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

RAPGEF6 HIVEP2 TTC3 MAP3K1 OSBPL8

9.32e-051671215ced6ed9b412739c6ced622523347c10295edbf53
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NEB GDF9 RYR3 STARD9 RECQL5

9.86e-05169121516c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9

USP53 CFAP47 TEX2 RYR3 P3H2

1.04e-04171121574be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ABCB1 KIAA1217

1.10e-04173121595c723b09254ae7131fe5ba0841472502e83269b
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ZDHHC23 KIAA1217

1.13e-04174121599eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ABCB1 KIAA1217

1.19e-04176121572a2a01618ce836bc843395d5095e9090759b4a6
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ABCB1 KIAA1217

1.22e-0417712154c069f0d044a96118090b85ca592a21d6b5d9399
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ABCB1 KIAA1217

1.22e-041771215bde307e67ad8e48a5ff4c0827015f4688f6b3e46
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9

FAM13C ANKRD26 FAM171A1 VPS13D KAT6B

1.22e-041771215e8ab340b20cd41554c3841fe980e078e878af35f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ABCB1 KIAA1217

1.29e-0417912157954c0026754ab869b88ab7feb13c2f27d6e272d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CYP4A11 CYP4A22 VSTM4 P3H2 PLG

1.29e-04179121578fae47ec9bff4e0159a86a281e831d7f8ee925a
ToppCellCOVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

GABRE SYNPO SORBS1 ARHGEF7 KIAA1217

1.32e-041801215493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCellfacs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP100 ESYT1 AKNA MAP3K1 BRWD1

1.32e-04180121587fb1fdbc49c808bb5f6fe9fb747057b45fa78d0
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ABCB1 KIAA1217

1.32e-041801215b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCDH11Y ADTRP RYR3 ABCB1 KIAA1217

1.36e-04181121508f44323bf71b6004a921bbc969c954c75feeb66
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 MAP3K1 ABCB1 DLG2 SDC2

1.36e-0418112156956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor

SORBS1 RYR3 NFATC1 CLPTM1 MTUS2

1.39e-041821215ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 RYR3 TMEM150C GOLIM4 DLG2

1.43e-0418312153c516fe5083f02bad1f464ed284010b4131a833c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 RYR3 TMEM150C GOLIM4 DLG2

1.43e-0418312159c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NEB DCX RYR3 TRANK1 ROS1

1.47e-0418412152cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NEB DCX RYR3 TRANK1 ROS1

1.47e-041841215ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NEB DCX RYR3 TRANK1 ROS1

1.47e-0418412152b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Marrow-T-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP100 ESYT1 AKNA MAP3K1 BRWD1

1.47e-041841215b12fb85a064f715a4f0ada1df8e422c359b573cf
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 RYR3 TMEM150C GOLIM4 DLG2

1.47e-0418412157294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCellfacs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP100 ESYT1 AKNA MAP3K1 BRWD1

1.51e-041851215e1fd0a807def8c2127194108b1a30c6de7024292
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 ARHGAP23 SYNPO RYR3 TMEM150C

1.51e-0418512159197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 ARHGAP23 SYNPO RYR3 TMEM150C

1.51e-041851215ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCell10x5'-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue

C9orf152 P3H2 SYK SDC2 MTUS2

1.51e-04185121523ffba9216729b5bdb30b35742ba2627bb1200bf
ToppCellCOPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class

HIVEP2 SORBS1 P3H2 DLG2 ROS1

1.58e-041871215030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

RAPGEF6 HIVEP2 MAP3K1 NFATC1 ARID5B

1.62e-041881215939790f133eac9c12d08db6ddb5f08f5107844e3
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 SIPA1L3 MAP3K1 P3H2 SDC2

1.62e-04188121563a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCellHealthy_donor-NK_CD56bright|World / disease group, cell group and cell class (v2)

AKNA ABCB1 ZNF836 STARD9 GOLIM4

1.62e-0418812158ee359199c61c3b5b498ac35148390db5cc1a836
ToppCell21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class

SGIP1 MYH7B CHGA NEB DCX

1.62e-041881215e78d4f7a5d28c77503cb041ff585d13df4c88bd2
ToppCellhuman_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

ITSN1 SIPA1L3 PIK3C2A P3H2 KIAA1217

1.62e-041881215b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

USP53 CYP4A11 ARHGEF7 P3H2 PLG

1.66e-041891215a48df46274d51e84ffb40264646de7346104efb9
ToppCellHippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32

HIVEP2 SYNPO RYR3 ZDHHC23 TMEM150C

1.66e-0418912154b90d181eb0a42814eeb23bc82e52fd3a12392a7
ToppCell3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH7B CHGA NEB DCX CHRM5

1.70e-04190121540d8b3403f4e38436b961cd3a2e69826cbae3042
ToppCell3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH7B CHGA NEB DCX CHRM5

1.70e-041901215f6cbf6d292f488ada5f7581e1dceba6198b933d1
ToppCell3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH7B CHGA NEB DCX CHRM5

1.70e-041901215a9a705455019e28d655636de73b07540798f82e6
ToppCellP07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NUSAP1 SGIP1 VSTM4 NEIL3 SDC2

1.75e-041911215ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

FAM13C DCX DLG2 ANKFN1 SDC2

1.75e-04191121544b1f62fdee03b157fe545f2ae6ff84f8929a8ac
ToppCellControl-Multiplet-Multiplet|World / Disease state, Lineage and Cell class

SORBS1 P3H2 KIAA1217 DLG2 ROS1

1.79e-0419212151bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCellCOVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

RAPGEF6 HIVEP2 ADTRP TTC3 TMEM63A

1.79e-04192121535557254738844c27ffcd00f3287fbcc0a4d0f3b
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESYT1 UGGT1 CHGA NEB PRRC2B

1.83e-041931215471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCellControl-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ABCB1 FAM171A1 KIAA1217 TMEM150C FAM135A

1.83e-041931215e1d546165dcc2392f540162206852c4717d7306f
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESYT1 UGGT1 CHGA NEB PRRC2B

1.83e-041931215fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PARP14 MAP3K1 ARID5B SYK SRRM2

1.88e-041941215ff661419b697aef51a53fdeac8d37d870d65f491
ToppCelldroplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UGGT1 CHGA NCOR1 SRRM2 PRRC2B

1.88e-04194121592b39a935e8c577eb1123d706d168fa13cf3344c
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

RAPGEF6 AKNA NCOR1 TRANK1 KAT6B

1.92e-04195121583c125223e7ca0f08a31414b3a16347912564765
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UGGT1 CHGA TTC3 NCOR1 SRRM2

1.92e-0419512153e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UGGT1 CHGA TTC3 NCOR1 SRRM2

1.92e-0419512157796ea9247f4c63762f0de8490fed08b9717fa23
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SGIP1 BCLAF1 NEB SRRM2 SDC2

1.92e-0419512155c86fddd6d0530beecf45ea5ba6b823123847696
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

HIVEP2 FSIP2 ZNF469 TMEM150C PLG

2.02e-0419712154f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1
ToppCellParenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

HIVEP2 FSIP2 ZNF469 TMEM150C PLG

2.02e-0419712152cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9
ToppCellBronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

SORBS1 FSIP2 ZNF556 RECQL5 DLG2

2.02e-041971215f7ef62d78336812573148f8bfce401877ec4e29c
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HIVEP2 FSIP2 ZNF469 TMEM150C PLG

2.02e-0419712150f37afad46b94c748a149d9ee681472d7a3e6937
ToppCellMS-IIF-Lymphocyte-B-B_intermediate|IIF / Disease, condition lineage and cell class

SP100 SIPA1L3 SYNPO PARP14 SYK

2.06e-041981215d6b533c5e1d55e13b1e87ce3dbacb1564bcdcc64
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

BCLAF1 ANKRD26 TTC3 VPS13D OSBPL8

2.11e-04199121561b1ed2db71b96157b92b7535d1955a4033098da
ToppCell(02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition

SP100 BCLAF1 TTC3 ARID5B GOLIM4

2.11e-04199121518a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

BCLAF1 ITSN1 ANKRD26 TTC3 OSBPL8

2.11e-041991215fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellBronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

CHGA DCX C9orf152 P3H2 MTUS2

2.11e-041991215cd581d7330b471431ef427f8a4f5be553f70e068
ToppCellCOVID-19_Moderate|World / disease group, cell group and cell class

SP100 PARP14 TRANK1 CEBPZ ARID5B

2.11e-041991215952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell(05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition

USP53 BCLAF1 ITSN1 TTC3 OSBPL8

2.11e-041991215d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell(01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition

SP100 BCLAF1 ANKRD26 TTC3 GOLIM4

2.11e-041991215a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Mesoderm|10w / Sample Type, Dataset, Time_group, and Cell type.

SYNPO2L MAP3K1 ABCB1 GOLIM4 WIPF2

2.16e-0420012159ef226ebb0a7cdb9431e2fa65faa2a7d67da590d
ToppCellMacroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic

ITSN1 SORBS1 RYR3 NBPF19 SDC2

2.16e-042001215d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCellMacroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

ITSN1 SORBS1 RYR3 NBPF19 SDC2

2.16e-042001215f861509b54185d89931db64da1b9d81986cc7938
ToppCellfacs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAM13C CLPTM1 PACS2 OLIG2 TMEM63A

2.16e-042001215fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CFAP47 SORBS1 RYR3 PIK3C2A SDC2

2.16e-04200121507d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SP100 BCLAF1 PARP14 BIRC6 SRRM2

2.16e-04200121512f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellmild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SP100 SIPA1L3 SYNPO PARP14 SYK

2.16e-042001215fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class

SP100 HIVEP2 TRANK1 ARID5B TMEM63A

2.16e-042001215d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCellMacroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic

ITSN1 SORBS1 RYR3 NBPF19 SDC2

2.16e-04200121516f468217427921fa18c6d078ffa990eb019b257
ToppCellTracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SGIP1 VSTM4 STARD9 DLG2 SDC2

2.16e-042001215c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCellMacroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic

ITSN1 SORBS1 RYR3 NBPF19 SDC2

2.16e-0420012150442894c39eec69850c090957a5dc7bcecd21e04
ToppCellCOVID-19|World / Disease, condition lineage and cell class

SP100 BCLAF1 PARP14 ARID5B SRRM2

2.16e-0420012157dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellCOVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class

SP100 BCLAF1 AKNA PARP14 SRRM2

2.16e-04200121562c25042086f1afd1102e0720e933c2e476468fd
ToppCellBrain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type.

TTC3 DCX KAT6B MTUS2 PRRC2B

2.16e-0420012152a635694844ddabcd98462c5636a6f41a3f08a46
ToppCellMacroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic

ITSN1 SORBS1 RYR3 NBPF19 SDC2

2.16e-04200121501819446deeab9054f5cfe889d53bb49d137dbc0
DrugBenzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A

ZNF862 SPATA2 VPS13D SUGP1 PACS2 KAT6B PRRC2B TMEM63A

8.52e-0619611881843_DN
DrugDiphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A

SP100 ZNF862 ITSN1 VPS13D ZNF408 RECQL5 SUGP1 TMEM63A

8.52e-0619611884591_DN
DrugBupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; HL60; HG-U133A

ESYT1 ITSN1 LHX3 SPATA2 NCOR1 ZNF408 OLIG2 PRRC2B

8.84e-0619711881564_UP
DrugEthynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

ADTRP MAP3K1 ZNF10 TRANK1 WDCP ZNF408 SUGP1 SYK

9.18e-0619811886479_DN
DrugRifampicin [13292-46-1]; Down 200; 4.8uM; HL60; HT_HG-U133A

GCFC2 HIVEP2 ZNF862 MAP3K1 TRANK1 NFATC1 SUGP1 TMEM63A

9.52e-0619911882487_DN
DrugLansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A

HIVEP2 ZNF862 SPATA2 NFATC1 CLEC4A RECQL5 SUGP1

5.90e-0518911872967_DN
DrugDenatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A

GCFC2 HIVEP2 ANKRD26 SPATA2 MAP3K1 VPS13D PACS2

6.30e-0519111873123_DN
DrugPF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A

ITSN1 ANKRD26 CBL ZNF10 P3H2 RECQL5 SDC2

6.73e-0519311876421_UP
DrugDiphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A

TRIOBP MAP3K1 VPS13D WDCP SYK SDC2 TMEM63A

6.73e-0519311877447_DN
DrugCorticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A

HIVEP2 ZNF862 ITSN1 ADTRP RECQL5 SUGP1 TMEM63A

6.95e-0519411871307_DN
DrugNabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A

SP100 ZNF862 NEB ZNF10 VPS13D SUGP1 SDC2

7.18e-0519511875428_DN
Drug5151277; Up 200; 14uM; MCF7; HT_HG-U133A_EA

SP100 GCFC2 NEB MAP3K1 ZNF408 RECQL5 SUGP1

7.18e-051951187903_UP
DrugFurazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A

TRIOBP ZNF10 VPS13D RECQL5 SUGP1 SRRM2 SDC2

7.18e-0519511873358_DN
DrugMuramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A

ZNF862 VPS13D ARID5B KAT6B SDC2 TMEM63A BRWD1

7.41e-0519611871326_UP
DrugTriamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A

HIVEP2 SIPA1L3 SPATA2 VPS13D ARHGEF7 PRRC2B BRWD1

7.41e-0519611871861_DN
DrugFluspirilen [1841-19-6]; Down 200; 8.4uM; HL60; HT_HG-U133A

SIPA1L3 SPATA2 MAP3K1 NFATC1 NEIL3 KAT6B PRRC2B

7.41e-0519611873086_DN
DrugTrifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A

ZNF862 SIPA1L3 SPATA2 VPS13D CLPTM1 WIPF2 TMEM63A

7.65e-0519711875819_DN
DrugHydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A

SP100 ZNF862 TRIOBP ZNF10 VPS13D SUGP1 TMEM63A

7.65e-0519711872765_DN
DrugSpiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A

FAM13C ZNF862 ITSN1 SIPA1L3 RECQL5 SUGP1 TMEM63A

7.65e-0519711872558_DN
DrugEpitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A

GCFC2 ITSN1 SIPA1L3 ANKRD26 VPS13D SYK TMEM63A

7.65e-0519711877342_DN
DrugTiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A

SP100 SIPA1L3 CBL ZNF10 SRRM2 TMEM63A BRWD1

7.65e-0519711877311_UP
Drug(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; HL60; HT_HG-U133A

CBL NFATC1 CLEC4A RECQL5 SUGP1 PACS2 TMEM63A

7.90e-0519811872969_DN
Drug0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A

ITSN1 ANKRD26 NEB VPS13D P3H2 CLPTM1 SUGP1

7.90e-0519811876426_DN
DrugKawain [500-64-1]; Down 200; 17.4uM; HL60; HT_HG-U133A

CBL VPS13D CLPTM1 SUGP1 GOLIM4 PACS2 SDC2

7.90e-0519811872337_DN
DrugDizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A

HIVEP2 ZNF862 TRIOBP SYNPO SYK WIPF2 PRRC2B

7.90e-0519811872069_DN
DrugLysergol [602-85-7]; Up 200; 15.8uM; HL60; HT_HG-U133A

ZNF862 ITSN1 SIPA1L3 VPS13D WDCP PACS2 TMEM63A

8.15e-0519911871325_UP
DrugXylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A

HIVEP2 SIPA1L3 NCOR1 VPS13D SUGP1 NEIL3 SDC2

8.15e-0519911877020_DN
DrugS(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A

ZNF862 ADTRP CLEC4A RECQL5 CLPTM1 SUGP1 FAM135A

8.15e-0519911873082_DN
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

ITSN1 ANKRD26 VPS13D CEBPZ KAT6B SDC2 BRWD1

8.15e-0519911876923_DN
DiseaseNoonan syndrome (implicated_via_orthology)

CBL KAT6B

8.22e-0541102DOID:3490 (implicated_via_orthology)
DiseaseX-14939 measurement

CYP4A11 CYP4A22

2.05e-0461102EFO_0800747
DiseaseAttached earlobe

HIVEP2 KIAA1217

3.80e-0481102HP_0009907
Diseasetetradecanedioate measurement

CYP4A11 ANKRD26

4.87e-0491102EFO_0021057
Diseaseautosomal recessive polycystic kidney disease (biomarker_via_orthology)

CYP4A11 CYP4A22

7.41e-04111102DOID:0110861 (biomarker_via_orthology)
Diseasedodecanedioate measurement

CYP4A11 OLIG3

8.87e-04121102EFO_0021054
DiseaseHematologic Neoplasms

CBL ABCB1

8.87e-04121102C0376545
Diseasecreatine kinase measurement

NEB CKM ROS1

1.41e-03591103EFO_0004534
Diseaset-tau:beta-amyloid 1-42 ratio measurement

SGIP1 ZNF556 DLG2

1.94e-03661103EFO_0007708
Diseaseurate measurement, bone density

FSIP2 C9orf152 ARID5B DLG2 KAT6B OLIG2 FAM135A PRRC2B

2.26e-036191108EFO_0003923, EFO_0004531
Diseasenucleus accumbens volume

SP100 BIRC6

3.03e-03221102EFO_0006931
DiseaseNoonan Syndrome

CBL KAT6B

3.60e-03241102C0028326

Protein segments in the cluster

PeptideGeneStartEntry
PLRKGTKHLSPYATL

ESYT1

811

Q9BSJ8
PSLSKTDSYKRLHPE

BIRC6

4016

Q9NR09
PHSYPSKKTGLTLLA

ADTRP

146

Q96IZ2
KVILGRSDPKSHGSY

CYP4A11

106

Q02928
SKHADSKPAPLTPAY

ARHGEF7

606

Q14155
PRKENKEYASSGPAL

ANKRD26

596

Q9UPS8
SEFPAARLSNGKYPK

BCOR

381

Q6W2J9
PLSIKNPHRSGKPAY

C9orf152

201

Q5JTZ5
STTKLHSPGYPKQRT

MTUS2

961

Q5JR59
PSLGSHSTYKPSKLE

RBFA

61

Q8N0V3
SKNKYLHSPESRPVT

KAT6B

1041

Q8WYB5
NKPSIDSYSKSGHKP

ABCB1

371

P08183
NLTPSGTLGKDYHKS

FAM171A1

446

Q5VUB5
KHPPGDEIYRKGSIS

KAT7

391

O95251
SPAHKKPKTAQYSSP

NEIL3

461

Q8TAT5
YSFPKPGHRKSSPAQ

SYK

296

P43405
PKSPSLQSETVHYKR

MGRN1

151

O60291
PKPHSRSSSAYRKSA

GPR50

386

Q13585
SKYGFPNKHSLSSLP

FSIP2

2956

Q5CZC0
KLRSNLPAPSTKEYH

FAM135A

731

Q9P2D6
AAYKGKRRSDSPPHI

MYH7B

181

A7E2Y1
SHNKARTSPYPGSKV

NUDT9

61

Q9BW91
LKTKFPYTNHRTNPG

PIK3C2A

391

O00443
PKLHDLSPAAYTKGV

NFATC1

766

O95644
TLKSAYNTSPKPARH

LHX3

171

Q9UBR4
NYDHKLRPGIGEKPT

GABRE

81

P78334
KASLSRPLNYEPHKG

NUSAP1

361

Q9BXS6
DGYRGKTSPHTPNEK

P3H2

491

Q8IVL5
KPKLRPYFEGLSHSS

PACS2

316

Q86VP3
KHLSPLNYKTEEPAS

TMEM63A

721

O94886
PYAHGPSVRKLSKIA

OLIG3

111

Q7RTU3
PGRAEDTKLYAPTHK

GOLIM4

296

O00461
RQGKEAYPTPTKDLH

OSBPL8

46

Q9BZF1
PGNATISKAGKLPYH

PARP14

861

Q460N5
YVASVQGSAPSPRKK

RGPD3

11

A6NKT7
KAPKHYGDTTLLREP

CEFIP

301

Q711Q0
LYPKSAVENKTSPHS

GCFC2

626

P16383
YSPPLHKNLDAREKS

BCLAF1

511

Q9NYF8
KVILGRSDPKSHGSY

CYP4A22

106

Q5TCH4
RSDPKSHGSYKFLAP

CYP4A22

111

Q5TCH4
ADSFRYPKTGTANPK

DPP8

326

Q6V1X1
IELKPCRSHGKSNPY

ITSN1

1606

Q15811
TPTSPGSLRKHKDLY

DCX

336

O43602
PKDESYRPPKSRSHN

AKNA

371

Q7Z591
NGYKSHTPAPSKTKF

BRWD1

1736

Q9NSI6
HPKIKPSSSANAIYS

CBL

661

P22681
VNKLCDKPASPRHYS

DLG2

351

Q15700
YATKEGIPKSNRSHL

GDF9

96

O60383
KILPSGLKYNARHPS

DCLRE1A

536

Q6PJP8
KEEPRYSGKEHPVSS

GPRIN1

256

Q7Z2K8
LGERKPSSAAYQKAP

SDC2

181

P34741
SPTKLTESRQYPKHD

CFAP47

2021

Q6ZTR5
ETSLDHPYEKPRKSS

INAVA

326

Q3KP66
YRNPKPHKGKENTDS

CEBPZ

761

Q03701
RPKSYHTPGQDKFLA

OR2AJ1

261

Q8NGZ0
KPDSPDLARHYKSAS

PCDH11Y

961

Q9BZA8
AHKDKSGAPPVRSIY

NUP35

81

Q8NFH5
NSLKTYSPEGRHKAP

OR4A8

221

P0C604
SPFGIPYSKLSQSKH

FAM83G

781

A6ND36
TLPGHTKAKQPYRED

MAP3K1

1226

Q13233
GARSYKTLPHVTPKT

SYNPO2L

691

Q9H987
YVASVQGSAPSPRKK

RGPD4

11

Q7Z3J3
PHKGYTLIPSAKSDN

RAPGEF6

1246

Q8TEU7
RQSHSGSISPYPKVK

SRRM2

986

Q9UQ35
PIISDRHGGYKPTDK

CKM

91

P06732
HGPYDSNQPHRKTKI

NBPF8

451

Q3BBV2
HGPYDSNQPHRKTKI

NBPF9

486

P0DPF3
HGPYDSNQPHRKTKI

NBPF11

486

Q86T75
HGPYDSNQPHRKTKI

NBPF14

146

Q5TI25
GPYDSNQPHRKTKIT

NBPF19

216

A0A087WUL8
VLYPSSDPKSSHLKG

SYNPO

586

Q8N3V7
KPQPHSSVVYSEAGK

NCOR1

1891

O75376
GKDSPNRHSKGEPQY

SIPA1L3

1251

O60292
RKYPDSHLPTLGSKT

KIAA1217

456

Q5T5P2
LLSISRPYKTKPTHG

MRPL48

41

Q96GC5
PYAHGPSVRKLSKIA

OLIG2

136

Q13516
NSAERKPGVKHAPYI

TMEM150C

41

B9EJG8
EYKPPSPSRASKRHQ

STARD9

1031

Q9P2P6
KKYRPSHGDKTSNPE

FAM13C

311

Q8NE31
KSPRPSSYKVILGAH

PLG

626

P00747
LHSYSTQKGPLKAGE

TRIOBP

1906

Q9H2D6
YLLSPAAAHRPKSQK

CHRM5

361

P08912
KKYPESLSRSGKPHH

ARID5B

966

Q14865
KHSAPSSPNAAKRLY

ANKFN1

86

Q8N957
PHPSLGYKEIRKGES

CHGA

256

P10645
TKSGFHPDPRQKALY

CLPTM1

171

O96005
ERTAPHKSNTGFPKL

CLEC4A

31

Q9UMR7
LKYHQRPKLSFPESS

USP53

1051

Q70EK8
AHYGGPSPEKKAKSS

RECQL5

721

O94762
LASLPGPVKSYSHAK

SUGP1

136

Q8IWZ8
SLYHKRSPPAKESAL

SPATA2

366

Q9UM82
AHKIGRKPPAFYTSA

ZC3H6

441

P61129
SPLKPLSSSGYASHK

RYR3

2881

Q15413
YSIRPEEPGSTKGKH

SGIP1

86

Q9BQI5
LNDYRKVSHSSGPKA

ARHGAP23

826

Q9P227
PHGYLAKKLHSPSDQ

ZNF408

301

Q9H9D4
QPPASFKKYRHISAG

TEX52

201

A6NCN8
AKGYRSVHPNLPSDK

SORBS1

131

Q9BX66
SEYRPKIKGEHPGLS

SP100

781

P23497
GKAFSRPSYLQTHEK

ZNF556

181

Q9HAH1
SNSPKPGSEDANYKR

TTC3

1276

P53804
ALQSKGYPLPHPKSS

PRRC2B

751

Q5JSZ5
SHKPNGPKESVRYQL

ROS1

1581

P08922
SAPKPKISGSIHYAL

ZNF518A

31

Q6AHZ1
HRAKKNPGYLSNPAS

ZDHHC23

186

Q8IYP9
PQKKAYLSHLSTGSG

ZNF862

106

O60290
AKKGPQPYSSPHSEL

ZNF469

1341

Q96JG9
SSLGISKGIHREKPY

ZNF10

251

P21506
PSRSYLRKNPDKFHG

ZNF26

141

P17031
LASHLSGYIPPKRKQ

GTF3A

321

Q92664
KPHRAAKGAPTSTVY

VSTM4

296

Q8IW00
HSSKAPAYNREKPLP

WIPF2

196

Q8TF74
STKATSHYKPLDPNI

TRANK1

1171

O15050
RLHNGKKSSSVYPLS

WDCP

581

Q9H6R7
DTVSYKPPDSKLNLH

TEX2

231

Q8IWB9
HSGGYPRKKISSLNP

HIVEP2

146

P31629
KYRSSPCPNVKHGDE

UNK

251

Q9C0B0
SVAKGTDPNYHPSKK

THEGL

311

P0DJG4
LQDYARSHGKKLPPA

PPIP5K1

1041

Q6PFW1
KPLLFKGDHRYPSSN

UGGT1

176

Q9NYU2
SSKLARYHRNPTGEK

ZNF836

706

Q6ZNA1
SRGAPKPSSLAQKEY

VPS13D

1691

Q5THJ4
HSKLYIGSKRTASPP

MYO3A

391

Q8NEV4
YKEFLPSRSGPKEHS

MYO3A

1541

Q8NEV4
NKAKPRGYTTIHDTP

NEB

5481

P20929